CCCC
Price
$1.35
Change
-$0.00 (-0.00%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
96.57M
76 days until earnings call
CTNM
Price
$3.90
Change
+$0.04 (+1.04%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
99.09M
Interact to see
Advertisement

CCCC vs CTNM

Header iconCCCC vs CTNM Comparison
Open Charts CCCC vs CTNMBanner chart's image
C4 Therapeutics
Price$1.35
Change-$0.00 (-0.00%)
Volume$45.62K
Capitalization96.57M
Contineum Therapeutics
Price$3.90
Change+$0.04 (+1.04%)
Volume$1.7K
Capitalization99.09M
CCCC vs CTNM Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. CTNM commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and CTNM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CCCC: $1.36 vs. CTNM: $3.86)
Brand notoriety: CCCC and CTNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 84% vs. CTNM: 98%
Market capitalization -- CCCC: $96.57M vs. CTNM: $99.09M
CCCC [@Biotechnology] is valued at $96.57M. CTNM’s [@Biotechnology] market capitalization is $99.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCTNM’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CTNM’s FA Score: 1 green, 4 red.
According to our system of comparison, both CCCC and CTNM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 5 TA indicator(s) are bullish while CTNM’s TA Score has 4 bullish TA indicator(s).

  • CCCC’s TA Score: 5 bullish, 3 bearish.
  • CTNM’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than CTNM.

Price Growth

CCCC (@Biotechnology) experienced а -0.73% price change this week, while CTNM (@Biotechnology) price change was +0.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

CTNM is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($99.1M) and CCCC($96.6M) have the same market capitalization . CCCC YTD gains are higher at: -62.222 vs. CTNM (-73.686). CTNM has higher annual earnings (EBITDA): -42M vs. CCCC (-102.74M). CCCC (215M) and CTNM (205M) have equal amount of cash in the bank . CTNM has less debt than CCCC: CTNM (6.26M) vs CCCC (64.4M). CCCC has higher revenues than CTNM: CCCC (39.8M) vs CTNM (0).
CCCCCTNMCCCC / CTNM
Capitalization96.6M99.1M97%
EBITDA-102.74M-42M245%
Gain YTD-62.222-73.68684%
P/E RatioN/A26.40-
Revenue39.8M0-
Total Cash215M205M105%
Total Debt64.4M6.26M1,029%
TECHNICAL ANALYSIS
Technical Analysis
CCCCCTNM
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
83%
Bullish Trend 8 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLPFX13.51N/A
N/A
Catalyst Nasdaq-100 Hedged Equity I
WISIX13.85-0.01
-0.07%
William Blair International Sm Cap Gr I
HFESX52.28-0.10
-0.19%
Janus Henderson European Focus S
MRGRX54.54-0.99
-1.78%
MFS Core Equity I
RTSSX38.09-1.10
-2.81%
Russell Inv Tax-Managed US Mid&Sm Cap S

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-8.11%
KYMR - CCCC
63%
Loosely correlated
-4.17%
CRBU - CCCC
55%
Loosely correlated
-7.73%
BEAM - CCCC
54%
Loosely correlated
-2.99%
FATE - CCCC
53%
Loosely correlated
-6.40%
NTLA - CCCC
52%
Loosely correlated
-4.86%
More

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with GUTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then GUTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+0.65%
GUTS - CTNM
34%
Loosely correlated
-12.38%
CCCC - CTNM
34%
Loosely correlated
-8.11%
SLN - CTNM
31%
Poorly correlated
N/A
ARMP - CTNM
29%
Poorly correlated
-6.67%
SVRA - CTNM
28%
Poorly correlated
-7.18%
More